Global Medical Foods Market to reach USD 28.73 billion by 2027.Global Medical Foods Market is valued approximately at USD 20.15 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2021-2027. Medical foods are principally formulated foods, that are taken orally or by tube under the supervision of health professionals to provide the nutrients to patients not present in a normal diet, for the management of diseases such as Alzheimer's, nutritional deficiency, depression and others. Increasing prevalence of malnutrition, Alzheimer's and diabetes, growing geriatric population, and continuous innovation medical foods are leading the market towards growth. For instance, according to USA Against Alzheimer's report of 2021, about 6.2 million people in United States are living with Alzheimer's, and by 2050, 2.7 million Americans 65 and older will have Alzheimer's. Also, according to International Diabetes Foundation, in 2019, 463 million people worldwide were living with diabetes which is expected to reach 578 million by 2030. Furthermore, growing investments by market players in form of mergers, acquisitions, research and development and others are expected to boost the demand in coming years. However, lack of awareness regarding use of medical foods may hamper the growth during forecast period.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are considered for the regional analysis of the global Medical Foods Market. North America is the dominating region across the world in terms of market share due to growing awareness regarding medical foods and increasing problem of Alzheimer's disease. Whereas Asia pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to improved education towards medical foods and continuous innovation.
Major market player included in this report are:

Danone
Nestle Nutrition
Abbott Nutrition
Targeted Medical Pharma Inc.
Primus Pharmaceuticals Inc.
Mead Johnson & Company, LLC
Medtrition Inc.
Fresenius Kabi AG
Reckitt Benckiser Group plc
Metagenics, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:
Oral
Enteral
By Product:
Pills
Powder
Others
By Application:
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhea
Pathogen Related Infections
Diabetic Neuropathy
ADHD
Depression
Alzheimer's Disease
Nutritional Deficiency
Orphan Diseases
Other
By Sales Channel:
Online Sales
Retail Sales
Institutional Sales


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Medical Foods Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors